StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1

Christopher P Dillon1, Siddharth Balachandran2

  • 1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Cytokine
|December 3, 2015
PubMed

Insights

Tumor Necrosis Factor-alpha (TNF-α) signaling regulates cell fate. New research shows that IKK-α/β phosphorylation of RIPK1 kinase switches it from promoting cell death to survival, independent of NF-κB.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Immunology

Background:

  • Tumor Necrosis Factor-alpha (TNF-α) signaling pathways are crucial in mammalian biology, governing cell survival and death.
  • The kinase RIPK1 is central to these pathways, with its poly-ubiquitylation previously thought to dictate its role in NF-κB activation (survival) versus cell death signaling.
  • A simplified model posits TNF-α receptor signaling bifurcates into NF-κB-mediated survival and death-inducing signals.

Discussion:

  • This study reveals that phosphorylation of RIPK1 by IKK-α and IKK-β acts as a critical switch in TNF-α receptor signaling.
  • Phosphorylation by IKKs inhibits RIPK1's ability to form pro-apoptotic complexes with FADD and caspase 8, thereby preventing apoptosis.
  • These IKKs also confer protection against RIPK1-dependent necroptosis, independent of NF-κB transcriptional activity.

Key Insights:

  • Phosphorylation of RIPK1 by IKK-α/β is a novel mechanism regulating cell death downstream of TNF-α receptor.
  • This phosphorylation event dampens RIPK1's kinase activity and its assembly into death-inducing complexes.
  • RIPK1 kinase activity is regulated by both ubiquitylation and phosphorylation states.

Outlook:

  • Further investigation into RIPK1 phosphorylation by IKKs could uncover new therapeutic targets for diseases involving aberrant cell death.
  • Understanding this regulatory switch offers deeper insights into TNFR1-mediated cell fate decisions.
  • This work expands the known mechanisms controlling apoptosis and necroptosis signaling pathways.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...